Identification of regulated genes during transient cortical ischemia in mice by restriction-mediated differential display (RMDD)

Molecular Brain Research

Volumn 124, Issue 1, 2004, Pages 20-28

  Schneider, Armin ^a   Fischer, Achim ^a   Krüger, Carola ^a   Aronowski, Jaroslaw ^b  

^a Axaron Bioscience AG   (Germany)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Cortical ischemia; Disorders of the nervous system; Focal cerebral ischemia; Fragment display; Gene expression; Ischemia; Mouse

Indexed keywords

METALLOTHIONEIN; METALLOTHIONEIN II; MITOCHONDRIAL PROTEIN; PHOSPHOPROTEIN; RECEPTOR ACTIVITY MODIFYING PROTEIN; RECEPTOR ACTIVITY MODIFYING PROTEIN 2; TRANSCRIPTION FACTOR IIB; UNCLASSIFIED DRUG;

ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CONTROLLED STUDY; DIFFERENTIAL DISPLAY; GENE CONTROL; GENE EXPRESSION; GENE SEQUENCE; GENETIC TRANSCRIPTION; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; QUANTITATIVE ASSAY; REAL TIME POLYMERASE CHAIN REACTION; REPERFUSION; TRANSIENT ISCHEMIC ATTACK; UPREGULATION;

ANIMALS; BLOTTING, NORTHERN; CAROTID ARTERY DISEASES; CLONING, MOLECULAR; COMPUTATIONAL BIOLOGY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INFARCTION, MIDDLE CEREBRAL ARTERY; ISCHEMIC ATTACK, TRANSIENT; MICE; MICE, INBRED C57BL; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; POLYMERASE CHAIN REACTION; RNA; TIME FACTORS;

EID: 1942452957     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.molbrainres.2004.02.002     Document Type: Article

References (56)

1. Aronowski J., Grotta J.C., Strong R., Waxham M.N. Interplay between the gamma isoform of PKC and calcineurin in regulation of vulnerability to focal cerebral ischemia. J. Cereb. Blood Flow Metab. 20:2000;343-349.
2. Bidmon H.J., Kato K., Schleicher A., Witte O.W., Zilles K. Transient increase of manganese-superoxide dismutase in remote brain areas after focal photothrombotic cortical lesion. Stroke. 29:1998;203-210. (discussion 211).
3. Bonthius D.J., Steward O. Induction of cortical spreading depression with potassium chloride upregulates levels of messenger RNA for glial fibrillary acidic protein in cortex and hippocampus: inhibition by MK-801. Brain Res. 618:1993;83-94.
4. Brabeck C., Michetti F., Geloso M.C., Corvino V., Goezalan F., Meyermann R., Schluesener H.J. Expression of EMAP-II by activated monocytes/microglial cells in different regions of the rat hippocampus after trimethyltin-induced brain damage. Exp. Neurol. 177:2002;341-346.
5. Brambrink A.M., Schneider A., Noga H., Astheimer A., Gotz B., Korner I., Heimann A., Welschof M., Kempski O. Tolerance-Inducing dose of 3-nitropropionic acid modulates bcl-2 and bax balance in the rat brain: a potential mechanism of chemical preconditioning. J. Cereb. Blood Flow Metab. 20:2000;1425-1436.
6. Chang C.F., Lin S.Z., Chiang Y.H., Morales M., Chou J., Lein P., Chen H.L., Hoffer B.J., Wang Y. Intravenous administration of bone morphogenetic protein-7 after ischemia improves motor function in stroke rats. Stroke. 34:2003;558-564.
7. Chomczynski P., Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162:1987;156-159.
8. Ebisawa T., Fukuchi M., Murakami G., Chiba T., Tanaka K., Imamura T., Miyazono K. Smurf1 interacts with transforming growth factor-beta type I receptor through Smad7 and induces receptor degradation. J. Biol. Chem. 276:2001;12477-12480.
9. Fischer A. Restriction-mediated differential display (RMDD). Asubel F.M.et al. Current Protocols in Molecular Biology, Vol. 4 supplement 56. 2001;25B.24.17-25B.24.21 Wiley, Habaken.
10. Garrett K.P., Aso T., Bradsher J.N., Foundling S.I., Lane W.S., Conaway R.C., Conaway J.W. Positive regulation of general transcription factor SIII by a tailed ubiquitin homolog. Proc. Natl. Acad. Sci. U. S. A. 92:1995;7172-7176.
11. Gass P., Spranger M., Herdegen T., Bravo R., Kock P., Hacke W., Kiessling M. Induction of FOS and JUN proteins after focal ischemia in the rat: differential effect of the N-methyl-D-aspartate receptor antagonist MK-801. Acta Neuropathol. 84:1992;545-553.
12. Guo X., Ying W., Wan J., Hu Z., Qian X., Zhang H., He F. Proteomic characterization of early-stage differentiation of mouse embryonic stem cells into neural cells induced by all-trans retinoic acid in vitro. Electrophoresis. 22:2001;3067-3075.
13. Hai T., Wolfgang C.D., Marsee D.K., Allen A.E., Sivaprasad U. ATF3 and stress responses. Gene Expr. 7:1999;321-335.
14. Herrera D.G., Robertson H.A. Application of potassium chloride to the brain surface induces the c-fos proto-oncogene: reversal by MK-801. Brain Res. 510:1990;166-170.
15. Iqbal Chowdhury G.M., Liu Y., Tanaka M., Fujioka T., Ishikawa A., Nakamura S. Cortical spreading depression affects Fos expression in the hypothalamic paraventricular nucleus and the cerebral cortex of both hemispheres. Neurosci. Res. 45:2003;149-155.
16. Kamura T., Sato S., Haque D., Liu L., Kaelin W.G. Jr., Conaway R.C., Conaway J.W. The Elongin BC complex interacts with the conserved SOCS-box motif present in members of the SOCS, ras, WD-40 repeat, and ankyrin repeat families. Genes Dev. 12:1998;3872-3881.
17. Keyvani K., Reinecke S., Abts H.F., Paulus W., Witte O.W. Suppression of proteasome C2 contralateral to ischemic lesions in rat brain. Brain Res. 858:2000;386-392.
18. Keyvani K., Witte O.W., Paulus W. Gene expression profiling in perilesional and contralateral areas after ischemia in rat brain. J. Cereb. Blood Flow Metab. 22:2002;153-160.
19. Kibel A., Iliopoulos O., DeCaprio J.A., Kaelin W.G. Jr. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B and C. Science. 269:1995;1444-1446.
20. Kim Y.D., Sohn N.W., Kang C., Soh Y. DNA array reveals altered gene expression in response to focal cerebral ischemia. Brain Res. Bull. 58:2002;491-498.
21. Kitagawa M., Mukai H., Ono Y. Molecular cloning and characterization of a novel mitochondrial phosphoprotein, MIPP65, from rat liver. Exp. Cell Res. 235:1997;71-78.
22. Knies U.E., Behrensdorf H.A., Mitchell C.A., Deutsch U., Risau W., Drexler H.C., Clauss M. Regulation of endothelial monocyte-activating polypeptide II release by apoptosis. Proc. Natl. Acad. Sci. U. S. A. 95:1998;12322-12327.
23. Koistinaho J., Chan P.H. Spreading depression-induced cyclooxygenase-2 expression in the cortex. Neurochem. Res. 25:2000;645-651.
24. Kokaia Z., Zhao Q., Kokaia M., Elmer E., Metsis M., Smith M.L., Siesjo B.K., Lindvall O. Regulation of brain-derived neurotrophic factor gene expression after transient middle cerebral artery occlusion with and without brain damage. Exp. Neurol. 136:1995;73-88.
25. Lin S.Z., Hoffer B.J., Kaplan P., Wang Y. Osteogenic protein-1 protects against cerebral infarction induced by MCA ligation in adult rats. Stroke. 30:1999;126-133.
26. Liu Y., Belayev L., Zhao W., Busto R., Saul I., Alonso O., Ginsberg M.D. The effect of bone morphogenetic protein-7 (BMP-7) on functional recovery, local cerebral glucose utilization and blood flow after transient focal cerebral ischemia in rats. Brain Res. 905:2001;81-90.
27. Lu A., Ran R., Parmentier-Batteur S., Nee A., Sharp F.R. Geldanamycin induces heat shock proteins in brain and protects against focal cerebral ischemia. J. Neurochem. 81:2002;355-364.
28. Lu A., Tang Y., Ran R., Clark J.F., Aronow B.J., Sharp F.R. Genomics of the periinfarction cortex after focal cerebral ischemia. J. Cereb. Blood Flow Metab. 23:2003;786-810.
29. Matschurat S., Knies U.E., Person V., Fink L., Stoelcker B., Ebenebe C., Behrensdorf H.A., Schaper J., Clauss M. Regulation of EMAP II by hypoxia. Am. J. Pathol. 162:2003;93-103.
30. Matsushima K., Hogan M.J., Hakim A.M. Cortical spreading depression protects against subsequent focal cerebral ischemia in rats. J. Cereb. Blood Flow Metab. 16:1996;221-226.
31. Matsushima K., Schmidt-Kastner R., Hogan M.J., Hakim A.M. Cortical spreading depression activates trophic factor expression in neurons and astrocytes and protects against subsequent focal brain ischemia. Brain Res. 807:1998;47-60.
32. Matsuzawa A., Hattori K., Aoki J., Arai H., Inoue K. Protection against oxidative stress-induced cell death by intracellular platelet-activating factor-acetylhydrolase II. J. Biol. Chem. 272:1997;32315-32320.
33. McLatchie L.M., Fraser N.J., Main M.J., Wise A., Brown J., Thompson N., Solari R., Lee M.G., Foord S.M. RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor. Nature. 393:1998;333-339.
34. Mies G., Paschen W., Hossmann K.A. Cerebral blood flow, glucose utilization, regional glucose, and ATP content during the maturation period of delayed ischemic injury in gerbil brain. J. Cereb. Blood Flow Metab. 10:1990;638-645.
35. Osuga H., Osuga S., Wang F., Fetni R., Hogan M.J., Slack R.S., Hakim A.M., Ikeda J.E., Park D.S. Cyclin-dependent kinases as a therapeutic target for stroke. Proc. Natl. Acad. Sci. U. S. A. 97:2000;10254-10259.
36. Price D.H. P-TEFb, a cyclin-dependent kinase controlling elongation by RNA polymerase II. Mol. Cell. Biol. 20:2000;2629-2634.
37. Qi Y.F., Shi Y.R., Bu D.F., Pang Y.Z., Tang C.S. Changes of adrenomedullin and receptor activity modifying protein 2 (RAMP2) in myocardium and aorta in rats with isoproterenol-induced myocardial ischemia. Peptides. 24:2003;463-468.
38. Raghavendra Rao V.L., Bowen K.K., Dhodda V.K., Song G., Franklin J.L., Gavva N.R., Dempsey R.J. Gene expression analysis of spontaneously hypertensive rat cerebral cortex following transient focal cerebral ischemia. J. Neurochem. 83:2002;1072-1086.
39. Rajdev S., Hara K., Kokubo Y., Mestril R., Dillmann W., Weinstein P.R., Sharp F.R. Mice overexpressing rat heat shock protein 70 are protected against cerebral infarction. Ann. Neurol. 47:2000;782-791.
40. Reinecke S., Lutzenburg M., Hagemann G., Bruehl C., Neumann-Haefelin T., Witte O.W. Electrophysiological transcortical diaschisis after middle cerebral artery occlusion (MCAO) in rats. Neurosci. Lett. 261:1999;85-88.
41. Scheel J., Von Brevern M.C., Horlein A., Fischer A., Schneider A., Bach A. Yellow pages to the transcriptome. Pharmacogenomics. 3:2002;791-807.
42. Schmidt-Kastner R., Zhang B., Belayev L., Khoutorova L., Amin R., Busto R., Ginsberg M.D. DNA microarray analysis of cortical gene expression during early recirculation after focal brain ischemia in rat. Mol. Brain Res. 108:2002;81-93.
43. Schneider A., Martin-Villalba A., Weih F., Vogel J., Wirth T., Schwaninger M. NF-kappaB is activated and promotes cell death in focal cerebral ischemia. Nat. Med. 5:1999;554-559.
44. Senderowicz A.M. Novel direct and indirect cyclin-dependent kinase modulators for the prevention and treatment of human neoplasms. Cancer Chemother. Pharmacol. 52(Suppl. 1):2003;S61-S73.
45. Serrano J., Alonso D., Encinas J.M., Lopez J.C., Fernandez A.P., Castro-Blanco S., Fernandez-Vizarra P., Richart A., Bentura M.L., Santacana M., Uttenthal L.O., Cuttitta F., Rodrigo J., Martinez A. Adrenomedullin expression is up-regulated by ischemia-reperfusion in the cerebral cortex of the adult rat. Neuroscience. 109:2002;717-731.
46. Shalak V., Kaminska M., Mitnacht-Kraus R., Vandenabeele P., Clauss M., Mirande M. The EMAPII cytokine is released from the mammalian multisynthetase complex after cleavage of its p43/proEMAPII component. J. Biol. Chem. 276:2001;23769-23776.
47. Soriano M.A., Tessier M., Certa U., Gill R. Parallel gene expression monitoring using oligonucleotide probe arrays of multiple transcripts with an animal model of focal ischemia. J. Cereb. Blood Flow Metab. 20:2000;1045-1055.
48. Stenzel-Poore M.P., Stevens S.L., Xiong Z., Lessov N.S., Harrington C.A., Mori M., Meller R., Rosenzweig H.L., Tobar E., Shaw T.E., Chu X., Simon R.P. Effect of ischaemic preconditioning on genomic response to cerebral ischaemia: similarity to neuroprotective strategies in hibernation and hypoxia-tolerant states. Lancet. 362:2003;1028-1037.
49. Stroemer R.P., Kent T.A., Hulsebosch C.E. Neocortical neural sprouting, synaptogenesis, and behavioral recovery after neocortical infarction in rats. Stroke. 26:1995;2135-2144.
50. Trendelenburg G., Prass K., Priller J., Kapinya K., Polley A., Muselmann C., Ruscher K., Kannbley U., Schmitt A.O., Castell S., Wiegand F., Meisel A., Rosenthal A., Dirnagl U. Serial analysis of gene expression identifies metallothionein-II as major neuroprotective gene in mouse focal cerebral ischemia. J. Neurosci. 22:2002;5879-5888.
51. van Lookeren Campagne M.V., Thibodeaux H., van Bruggen N., Cairns B., Lowe D.G. Increased binding activity at an antioxidant-responsive element in the metallothionein-1 promoter and rapid induction of metallothionein-1 and -2 in response to cerebral ischemia and reperfusion. J. Neurosci. 20:2000;5200-5207.
52. Wang Y., Chang C.F., Morales M., Chou J., Chen H.L., Chiang Y.H., Lin S.Z., Cadet J.L., Deng X., Wang J.Y., Chen S.Y., Kaplan P.L., Hoffer B.J. Bone morphogenetic protein-6 reduces ischemia-induced brain damage in rats. Stroke. 32:2001;2170-2178.
53. Waxham M.N., Grotta J.C., Silva A.J., Strong R., Aronowski J. Ischemia-induced neuronal damage: a role for calcium/calmodulin-dependent protein kinase II. J. Cereb. Blood Flow Metab. 16:1996;1-6.
54. Wu P.C., Alexander H.R., Huang J., Hwu P., Gnant M., Berger A.C., Turner E., Wilson O., Libutti S.K. In vivo sensitivity of human melanoma to tumor necrosis factor (TNF)-alpha is determined by tumor production of the novel cytokine endothelial-monocyte activating polypeptide II (EMAPII). Cancer Res. 59:1999;205-212.
55. Yanamoto H., Hashimoto N., Nagata I., Kikuchi H. Infarct tolerance against temporary focal ischemia following spreading depression in rat brain. Brain Res. 784:1998;239-249.
56. Zhu H., Kavsak P., Abdollah S., Wrana J.L., Thomsen G.H. A SMAD ubiquitin ligase targets the BMP pathway and affects embryonic pattern formation. Nature. 400:1999;687-693.